Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Biochemical Society Transactions
|
September 23, 2011
Combining modelling and mutagenesis studies of synaptic vesicle protein 2A to identify a series of residues involved in racetam binding
Jiye Shi, Dina Anderson, Berkley A Lynch, et al.
Plos One
|
February 19, 2015
Exploring the interaction of SV2A with racetams using homology modelling, molecular dynamics and site-directed mutagenesis
Joanna Lee, Veronique Daniels, Zara A Sands, et al.
Journal of Chemical Information and Modeling
|
July 17, 2013
Development of dimethyl sulfoxide solubility models using 163,000 molecules: using a domain applicability metric to select more reliable predictions
Igor V Tetko, Sergii Novotarskyi, Iurii Sushko, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 28, 2006
First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives
Laurent Provins, Bernard Christophe, Pierre Danhaive, et al.
Soins. Gerontologie
|
June 23, 2007
[Multidisciplinary management of elderly patients with Parkinson's disease]
Pierre Koskas, Sandryne Stirati, Jérôme Lagadec, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 8, 2017
Crystal structure of the adenosine A<sub>2A</sub> receptor bound to an antagonist reveals a potential allosteric pocket
Bingfa Sun, Priti Bachhawat, Matthew Ling-Hon Chu, et al.
Biochemical Pharmacology
|
May 30, 2002
Metal-organic compounds: a new approach for drug discovery. N1-(4-methyl-2-pyridyl)-2,3,6-trimethoxybenzamide copper(II) complex as an inhibitor of human immunodeficiency virus 1 protease
Florence Lebon, Nicole Boggetto, Marie Ledecq, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
Towards a KCC2 blocker pharmacophore model
Florence Lebon, Cécile Pégurier, Marie Ledecq, et al.
Nature Communications
|
June 4, 2021
Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist
Bingfa Sun, Dan Feng, Matthew Ling-Hon Chu, et al.
Nature
|
November 19, 2013
Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A
Roger M Benoit, Daniel Frey, Manuel Hilbert, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Biochemical Society Transactions
|
September 23, 2011
Combining modelling and mutagenesis studies of synaptic vesicle protein 2A to identify a series of residues involved in racetam binding
Jiye Shi, Dina Anderson, Berkley A Lynch, et al.
Plos One
|
February 19, 2015
Exploring the interaction of SV2A with racetams using homology modelling, molecular dynamics and site-directed mutagenesis
Joanna Lee, Veronique Daniels, Zara A Sands, et al.
Journal of Chemical Information and Modeling
|
July 17, 2013
Development of dimethyl sulfoxide solubility models using 163,000 molecules: using a domain applicability metric to select more reliable predictions
Igor V Tetko, Sergii Novotarskyi, Iurii Sushko, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 28, 2006
First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives
Laurent Provins, Bernard Christophe, Pierre Danhaive, et al.
Soins. Gerontologie
|
June 23, 2007
[Multidisciplinary management of elderly patients with Parkinson's disease]
Pierre Koskas, Sandryne Stirati, Jérôme Lagadec, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 8, 2017
Crystal structure of the adenosine A<sub>2A</sub> receptor bound to an antagonist reveals a potential allosteric pocket
Bingfa Sun, Priti Bachhawat, Matthew Ling-Hon Chu, et al.
Biochemical Pharmacology
|
May 30, 2002
Metal-organic compounds: a new approach for drug discovery. N1-(4-methyl-2-pyridyl)-2,3,6-trimethoxybenzamide copper(II) complex as an inhibitor of human immunodeficiency virus 1 protease
Florence Lebon, Nicole Boggetto, Marie Ledecq, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
Towards a KCC2 blocker pharmacophore model
Florence Lebon, Cécile Pégurier, Marie Ledecq, et al.
Nature Communications
|
June 4, 2021
Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist
Bingfa Sun, Dan Feng, Matthew Ling-Hon Chu, et al.
Nature
|
November 19, 2013
Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A
Roger M Benoit, Daniel Frey, Manuel Hilbert, et al.
Page
of 2